Annual Accounts Receivable
$5.34 M
+$4.64 M+662.43%
31 March 2024
Summary:
Immunovant annual accounts receivable is currently $5.34 million, with the most recent change of +$4.64 million (+662.43%) on 31 March 2024. During the last 3 years, it has risen by +$4.74 million (+795.47%). IMVT annual accounts receivable is now -56.36% below its all-time high of $12.23 million, reached on 31 March 2022.IMVT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$1.88 M
-$541.00 K-22.38%
30 September 2024
Summary:
Immunovant quarterly accounts receivable is currently $1.88 million, with the most recent change of -$541.00 thousand (-22.38%) on 30 September 2024. Over the past year, it has increased by +$455.00 thousand (+32.02%). IMVT quarterly accounts receivable is now -85.76% below its all-time high of $13.18 million, reached on 30 June 2022.IMVT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +662.4% | +32.0% |
| 3 y3 years | +795.5% | - |
| 5 y5 years | - | - |
IMVT Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.4% | +795.5% | -85.8% | +168.0% |
| 5 y | 5 years | -56.4% | +795.5% | -85.8% | +214.8% |
| alltime | all time | -56.4% | +795.5% | -85.8% | +214.8% |
Immunovant Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.88 M(-22.4%) |
| June 2024 | - | $2.42 M(-54.7%) |
| Mar 2024 | $5.34 M(+662.4%) | $5.34 M(+418.7%) |
| Dec 2023 | - | $1.03 M(-27.6%) |
| Sept 2023 | - | $1.42 M(+72.7%) |
| June 2023 | - | $823.00 K(+17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | $700.00 K(-94.3%) | $700.00 K(-0.6%) |
| Dec 2022 | - | $704.00 K(-81.4%) |
| Sept 2022 | - | $3.78 M(-71.3%) |
| June 2022 | - | $13.18 M(+7.8%) |
| Mar 2022 | $12.23 M(+1951.8%) | $12.23 M(+1951.8%) |
| Mar 2021 | $596.00 K | $596.00 K |
FAQ
- What is Immunovant annual accounts receivable?
- What is the all time high annual accounts receivable for Immunovant?
- What is Immunovant annual accounts receivable year-on-year change?
- What is Immunovant quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Immunovant?
- What is Immunovant quarterly accounts receivable year-on-year change?
What is Immunovant annual accounts receivable?
The current annual accounts receivable of IMVT is $5.34 M
What is the all time high annual accounts receivable for Immunovant?
Immunovant all-time high annual accounts receivable is $12.23 M
What is Immunovant annual accounts receivable year-on-year change?
Over the past year, IMVT annual accounts receivable has changed by +$4.64 M (+662.43%)
What is Immunovant quarterly accounts receivable?
The current quarterly accounts receivable of IMVT is $1.88 M
What is the all time high quarterly accounts receivable for Immunovant?
Immunovant all-time high quarterly accounts receivable is $13.18 M
What is Immunovant quarterly accounts receivable year-on-year change?
Over the past year, IMVT quarterly accounts receivable has changed by +$455.00 K (+32.02%)